BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hastings ML, Brigande JV. Fetal gene therapy and pharmacotherapy to treat congenital hearing loss and vestibular dysfunction. Hear Res 2020;394:107931. [PMID: 32173115 DOI: 10.1016/j.heares.2020.107931] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 de Vrieze E, Cañas Martín J, Peijnenborg J, Martens A, Oostrik J, van den Heuvel S, Neveling K, Pennings R, Kremer H, van Wijk E. AON-based degradation of c.151C>T mutant COCH transcripts associated with dominantly inherited hearing impairment DFNA9. Mol Ther Nucleic Acids 2021;24:274-83. [PMID: 33815940 DOI: 10.1016/j.omtn.2021.02.033] [Reference Citation Analysis]
2 Peusner KD, Bell NM, Hirsch JC, Beraneck M, Popratiloff A. Understanding the Pathophysiology of Congenital Vestibular Disorders: Current Challenges and Future Directions. Front Neurol 2021;12:708395. [PMID: 34589045 DOI: 10.3389/fneur.2021.708395] [Reference Citation Analysis]
3 Renauld JM, Basch ML. Congenital Deafness and Recent Advances Towards Restoring Hearing Loss. Curr Protoc 2021;1:e76. [PMID: 33780161 DOI: 10.1002/cpz1.76] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wu X, Zhang L, Li Y, Zhang W, Wang J, Cai C, Lin X. Gene therapy via canalostomy approach preserves auditory and vestibular functions in a mouse model of Jervell and Lange-Nielsen syndrome type 2. Nat Commun 2021;12:697. [PMID: 33514733 DOI: 10.1038/s41467-020-20808-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhu J, Choi JW, Ishibashi Y, Isgrig K, Grati M, Bennett J, Chien W. Refining surgical techniques for efficient posterior semicircular canal gene delivery in the adult mammalian inner ear with minimal hearing loss. Sci Rep 2021;11:18856. [PMID: 34552193 DOI: 10.1038/s41598-021-98412-y] [Reference Citation Analysis]
6 Toms M, Pagarkar W, Moosajee M. Usher syndrome: clinical features, molecular genetics and advancing therapeutics. Ther Adv Ophthalmol 2020;12:2515841420952194. [PMID: 32995707 DOI: 10.1177/2515841420952194] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]